Ethan Schram is an Oncology physician affiliated with Scripps Research Institute. OpenAlex indexes 5 publications with 611 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
575 Lennon Ln Ste 153
Walnut Creek, CA 945982443
Telephone
925-433-8786Provider last certified this registry record 27 Feb 2025.
Industry payments
49 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202510 payments
- Janssen Biotech, Inc.Program year20256 payments
- Novartis Pharmaceuticals CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53%Aromatase Inhibitor12.8%Anastrozole100%Part D≥24 patientsKinase inhibitor8.3%Jakafi46%Imbruvica20%Brukinsa18%Tagrisso16%Part D<11 patients+ 8 more classes in this area
Nervous system
12.8%SSRI5.1%Citalopram Hbr65%Trazodone Hcl35%Part D<11 patientsBenzodiazepine3.2%Alprazolam58%Lorazepam42%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
12%Corticosteroid5%Prednisone100%Part D≥11 patientsSerotonin-3 Receptor Antagonist4.1%Ondansetron Hcl60%Ondansetron Odt40%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Physical Biology
2012 - Comparative morphometric analysis of breast-circulating tumor cells and their corresponding solid tumor cytology: A case study.
Journal of Clinical Oncology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Martin Friedlander, MD
Scripps Research Institute
Dianne McKay, MD
Scripps Research Institute
Anthony Hanson, MD
Scripps Research Institute
Paddy Barrett, MB, BCH, BAO
Scripps Research Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”